AlliedStar and Straumann Group announced an agreement where Straumann will acquire AlliedStar. As a portfolio company of CareCapital, AlliedStar’s founding team has built a strong product technology business in oral care. We also respect and support the decision of the founding team to continue developing the company under the ownership of a large dental technology group.
Since its founding, AlliedStar has demonstrated strong engineering excellence by creating a cutting-edge product that has received strong customer endorsement in both Asia and international markets. Intra-oral scanners are complex devices that must strike a balance between accuracy, usability and cost, all in a small form factor. It is important as dental treatments become more driven by software planning, which requires intra-oral scanning. This allows chair-side treatment by a single clinician to be empowered with remote collaboration, as well as enhances communication with patients. AlliedStar’s product positioning in the mass market will increase dental technology access to a broader population of clinicians and patients, which has been an important goal of CareCapital.
We are happy to see that going forward, AlliedStar will continue to serve existing channel partners, while CareCapital’s extensive network of dental companies will continue to support AlliedStar scanners.
This transaction demonstrates accelerated adoption of digital technology in chair-side settings in the clinic, and follows on the heels of the $2 billion sale of Medit and $600 million sale of Carestream Dental’s intra-oral scanning unit, another portfolio company of CareCapital. Patient expectation of technology adoption, as well as increased clinical productivity will continue to drive this trend.
Background of CareCapital
CareCapital is a private equity investor that focuses deeply on a few select healthcare verticals that have long-term growth, low regulatory intensity and global markets led by clinician communities. In each of its specialty areas, CareCapital establishes a leading worldwide portfolio. CareCapital supports its portfolio companies, which operate across 4 continents and 15 countries, by enhancing professional training, strengthening professional community, and innovating clinical technology.